Metsera
New York
About Metsera
Metsera is a biotechnology company that develops and manufactures therapies. The company's focus is on nutrient-stimulated hormone therapies for obesity and related conditions. Its portfolio includes both injectable and oral therapeutic candidates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $100K – $500K
- Total funding: $505.0M
- Funding stage: M&A
- Last round: Series B (Nov 2024)
- Ticker: nasdaq:MTSR
- Website: metsera.com
- Phone: +1 212 784-6595
Industries & Categories
Biopharma, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/metsera-18081 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.